Tina Dutt

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Journal: Blood
Published: May 05, 2025

The Highs and Lows of ADAMTS13 Activity.

The Highs and Lows of ADAMTS13 Activity.

Journal: Journal of clinical medicine
Published: June 18, 2024

Practical Considerations for the Use of the Rapid AcuStar® ADAMTS13 Activity Assay in the Diagnosis of Acute Thrombotic Thrombocytopenic Purpura (TTP).

Practical Considerations for the Use of the Rapid AcuStar® ADAMTS13 Activity Assay in the Diagnosis of Acute Thrombotic Thrombocytopenic Purpura (TTP).

Journal: Journal of clinical medicine
Published: May 09, 2024

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience.

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience.

Journal: Blood advances
Published: April 24, 2024

Shades of Grey-The brain in TTP.

Shades of Grey-The brain in TTP.

Journal: British journal of haematology
Published: December 22, 2023

Integrating psychology services for patients with thrombotic thrombocytopenic purpura: A specialist centre experience.

Integrating psychology services for patients with thrombotic thrombocytopenic purpura: A specialist centre experience.

Journal: EJHaem
Published: March 15, 2023

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

Journal: Blood
Published: October 27, 2022

Drug-induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data.

Drug-induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data.

Journal: British journal of haematology
Published: October 21, 2022

Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.

Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.

Journal: British journal of haematology
Published: September 29, 2022

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.

Journal: Blood
Published: May 13, 2022

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.

Journal: Journal of thrombosis and haemostasis : JTH
Published: December 14, 2021

Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.

Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.

Journal: British journal of haematology
Published: December 10, 2021
Showing 1-12 of 31

Last Updated: 09/26/2026